… a 5% incidence of periprocedural thrombus formation in patients undergoing PCI following
antithrombotic therapy with enoxaparin. Withholding of additional enoxaparin/UFH at the time …

… Sheaths were removed immediately after the procedure in patients treated with enoxaparin
… bolus of enoxaparin, and no antithrombin treatment was administered after the procedure. …

… and the potential for thrombosis or abrupt closure persist and … to enoxaparin, the sheath
could be removed 4 h after the … of antithrombotic therapy in PCI. Additionally, the use of closure …

… catheter occlusion after an average of 5.8 min whereas for UFH and all LMWH tested the …
the impact of antithrombin therapy using various LMWH on catheter thrombi formation. As this …

… 48 hours with subcutaneous injections of enoxaparin (1 mg [100 … LMW heparin injection,
followed by immediate percutaneous … closures or urgent revascularizations after PCI. The death/…

… Clinical outcomes after elective PCI were similar with the three antithrombotic co-therapies
studied in ASSENT-3. Although fewer patients needed urgent PCI with ABC and ENOX, …

… anticoagulants UFH and enoxaparin in preventing catheter thrombus formation. Blood …
, thrombus weight was lower following bolus treatment with UFH and enoxaparin compared …

… Efforts to further improve antithrombotic therapy in patients … or >6 h after the last injection of
fondaparinux or enoxaparin. … thrombus in those patients randomized to the enoxaparin group. …

… the first 30 days after randomization and secondary outcomes … One of the key concerns
regarding the use of LMWH with … al., macroscopic thrombus was observed on PCI equipment in 6 …

… 3 mg/dl within 48 h after the procedure that was considered a … This trial showed that changing
antithrombin therapy during the … with concomitant subcutaneous enoxaparin therapy 3 and …